Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
MoonLake Immunotherapeutics - Class A Ordinary Shares
(NQ:
MLTX
)
47.50
-0.54 (-1.12%)
Streaming Delayed Price
Updated: 12:30 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about MoonLake Immunotherapeutics - Class A Ordinary Shares
< Previous
1
2
3
4
5
Next >
Insiders Promise Not to Sell AMTD Digital (HKD) Stock Until 2025
June 26, 2023
AMTD Digital (HKD) stock is on the move Monday after insiders promised not to sell shares on the public market for a few more years.
Via
InvestorPlace
Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday
June 26, 2023
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Is FibroGen (FGEN) Stock Down 81% Today?
June 26, 2023
FibroGen (FGEN) stock is heading lower on Monday after the company's Phase 3 clinical trial failed to meet its primary endpoint.
Via
InvestorPlace
US Stocks Edge Higher; Goldman Sachs Downgrades Tesla To Neutral
June 26, 2023
U.S. stocks traded slightly higher this morning, with the Dow Jones gaining around 25 points on Monday. Following the market opening Monday, the Dow traded up 0.08% to 33,753.64 while the NASDAQ rose...
Via
Benzinga
The Latest Analyst Ratings for MoonLake
June 15, 2023
Via
Benzinga
What 10 Analyst Ratings Have To Say About MoonLake
May 01, 2023
Via
Benzinga
Where MoonLake Stands With Analysts
March 20, 2023
Via
Benzinga
Why Is MoonLake Immunotherapeutics (MLTX) Stock Up 93% Today?
June 26, 2023
MoonLake Immunotherapeutics (MLTX) stock is taking off on Monday after reporting positive results from a Phase 2 clinical trial.
Via
InvestorPlace
Why Mutual Fund Darling And Top 1% Stock MoonLake Immunotherapeutics Nearly Doubled
June 26, 2023
The company is treating a painful skin condition and could go up against AbbVie.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 26, 2023
Via
Benzinga
Lucid Stock Moved Into the Fast Lane, but This Nasdaq Biotech Was Monday's Big Winner
June 26, 2023
Markets looked poised to start the new week flat.
Via
The Motley Fool
Why MoonLake Immunotherapeutics Stock Is Shooting Higher Today
June 26, 2023
MoonLake Immunotherapeutics (NASDAQ: MLTX) released topline results from its Phase 2 MIRA trial evaluating the Nanobody sonelokimab in patients with moderate-to-severe
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2023
June 15, 2023
Via
Benzinga
10 Short Squeeze Stocks To Watch: Getty Images, Intuitive Machines, Wearable Devices & More
June 12, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...
Via
Benzinga
10 Short Squeeze Stocks To Watch: AirSculpt, Arrival, Toro, Groupon, Beam Global And More
May 30, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...
Via
Benzinga
10 Short Squeeze Stocks To Watch: Toro Corp, Greenidge Generation, Getty Images And More
May 22, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...
Via
Benzinga
10 Short Squeeze Stocks To Watch: Toro Corp, PaxMedica, Getty Images And More
May 15, 2023
Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High-short interest and high-cost to borrow are among the...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
May 01, 2023
Via
Benzinga
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 24, 2023
Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.
Via
Benzinga
10 Short Squeeze Stocks To Watch: Getty Images, Guardforce AI And 2 Stocks Moving Up Over 1,000 Positions On The Leaderboard
April 24, 2023
Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High short interest and high cost to borrow are among the...
Via
Benzinga
10 Short Squeeze Candidates: Getty Images Tops List, PaxMedica Rejoins Top Five, MicroStrategy Moves Up And More
April 10, 2023
Potential short squeeze plays gained steam in 2021 and continued through 2023 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2023
March 22, 2023
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 20, 2023
Gainers
Via
Benzinga
Charles Schwab To Rally Over 19%? Here Are 10 Other Analyst Forecasts For Monday
March 20, 2023
HC Wainwright & Co. cut the price target for 89bio, Inc. (NASDAQ: ETNB) from $27 to $25. HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. 89bio shares fell 5.2% to trade at $11.80 on...
Via
Benzinga
10 Short Squeeze Candidates: PaxMedica, Blue Apron, MicroStrategy And More
March 20, 2023
Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...
Via
Benzinga
5 Short Squeeze Candidates To Watch: Ambrx Biopharma, Kala Pharmaceuticals And This Company That Moved Up 1,403 Positions
March 13, 2023
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023
March 09, 2023
Via
Benzinga
10 Short Squeeze Candidates: China Jo-Jo Drugstores, Expion360, MoonLake, Silvergate And More
March 06, 2023
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...
Via
Benzinga
Cantor On MoonLake Immunotherapeutics - Initiates On Inexpensive Valuation, Strong Catalyst Path
February 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023
February 14, 2023
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.